export const DIFFERENTIATORS = [
  {
    tag: 'Therapeutic Focus',
    title: 'Orphan drug expertise',
    description:
      'Deep specialization in rare disease therapies, with 7 orphan drug filings completed in 3 years. We navigate the complexity that others avoid.',
  },
  {
    tag: 'Geographic Reach',
    title: 'Nordic-CEE market focus',
    description:
      'Direct commercial presence across 49 territories spanning the Nordics, Central-Eastern Europe, Baltics, Balkans, and Central Asia.',
  },
  {
    tag: 'Disease Area',
    title: 'SMA treatment pathway',
    description:
      'Established infrastructure for spinal muscular atrophy treatments. 5,100 diagnosed patients across priority markets with clear access pathways.',
  },
  {
    tag: 'Track Record',
    title: 'Regulatory precision',
    description:
      'Active dossiers in 32 of 49 markets. 14-month average filing-to-patient timeline. Built on 30 years of regional regulatory intelligence.',
  },
];
